Drug Profile
Glucagon - Novo Nordisk
Alternative Names: GlucaGenLatest Information Update: 29 Oct 2021
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Antihypoglycaemics; Pancreatic hormones
- Mechanism of Action Glucagon receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypoglycaemia
Most Recent Events
- 15 Jul 2014 Bedford Laboratories has been acquired by Hikma Pharmaceuticals
- 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
- 24 Sep 2009 Registered for Hypoglycaemia in Canada (SC)